Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Fractal announces new partnership with RAD to promote mental health support for Gamers globally

Gothenburg, October 30[th] – Fractal is proud to announce its new partnership with Rise Above the Disorder (RAD), a global non-profit organization dedicated to revolutionizing mental health care towards gamers worldwide by making it universally accessible. As a leading gaming company and proud advocate of gaming communities, Fractal is committed to championing mental health and making a positive social impact. This aligns perfectly with the aims of non-profit organization RAD. Founded by gamers, RAD’s mission is to provide universal mental health care. They want to eliminate the

EnerSys and CTEK Announce Strategic Collaboration to Bring High-Performance Chargers to Global Markets

CTEK, the global leader in battery charging solutions, has joined forces with EnerSys® (NYSE:ENS), the global leader in stored energy solutions for industrial applications and the manufacturer of ODYSSEY® batteries, to introduce a new era of high-quality chargers. This innovative partnership, which commenced in February 2023, is set to transform the battery charging landscape."We are thrilled to embark on this exciting partnership with Enersys and Odyssey. This collaboration signifies a commitment to innovation, sustainability, and delivering exceptional value to our customers. Together, we

VTT first in Finland to agree on research partnership with NATO within new framework

Press release 30 October 2023 VTT Technical Research Centre of Finland is the first Finnish organization to be approved by the NATO Communications and Information (NCI) Agency as its research partner within the Not-For-Profit Framework (NFPF). The agreement, signed on 25 October 2023, provides VTT the opportunity to participate in NATO’s research projects.The NCI Agency is responsible for this arrangement, which creates a framework for NATO's cooperation with academy and research institutes, defence laboratories, and other non-profit organizations. The cooperation complements the Agency'

Swedavia AB (publ) considers issue of hybrid capital securities

Swedavia AB (publ) is assessing market conditions for issuing new Swedish kronor-denominated hybrid capital securities. The aim of the transaction is to provide the best possible financial flexibility in the execution of Swedavia's strategy and mission, whilst securing Swedavia's capital structure objectives.NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, CANADA, JAPAN OR AUSTRALIA OR ANY OTHER JURISDICTION WHERE SUCH PUBLICATION, DISTRIBUTION OR RELEASE WOULD BY UNLAWFUL OR REQUIRE REGISTRATION OR ANY OTHER MEASURES. On

Nasdaq Stockholm delisting update

EnQuest PLC, 30 October 2023 EnQuest application to delist its shares from Nasdaq Stockholm - shareholder update As notified in a previous announcement on 5 September 2023, EnQuest PLC ('EnQuest' or the 'Company') plans to apply for a delisting of the Company's shares from Nasdaq Stockholm. The formal request to delist is therefore expected to be submitted to Nasdaq Stockholm on 5 December with the last day of trading likely to be around two weeks after the application date (the "Delisting Date"). The Company's shares will remain listed on the London Stock Exchange. In order to

Swedavia's interim report for the third quarter: continued recovery in travel, new commercial strategy and increased commercial revenues yields positive results

Swedavia reported improved operating income for the third quarter compared with the corresponding period of 2022. This was thanks to the continued recovery of the aviation market, despite global uncertainty and a weaker economy. Operating income totalled SEK 157 million, which is an increase of 110 per cent. Net revenue was SEK 1,613 million, which is an improvement of 23 per cent compared with the same period last year. The recovery in travel continued during the quarter, although this began to slow slightly towards the end of the period.More than 9 million passengers flew to or from

Hamlet BioPharma presented at the FS Market event on October 25th

The company was presented by Catharina Svanborg and Jan Zetterberg. To view the presentation, please use the link bekow: https://youtu.be/zkZsCx0y1Qw?si=bFGMAkwqGrkXLOd3 The presentation is also available on the Hamlet BioPharma homepage: https://hamletbiopharma.com/news/media-archive/    For further information, please contact: Catharina Svanborg, Chairman and Founder of Hamlet BioPharma catharina.svanborg@hamletpharma.com (catharina.svanborg@hamletpharma.com) Jan Zetterberg, advisor Hamlet BioPharma jan.zetterberg@zdur.se (jan.zetterberg@zdur.se)

#23-95 Unit issue in Imsys AB

The board of Imsys AB (the “Company”) has decided on a unit issue with preferential rights for the Company’s existing shareholders subject to approval from the general meeting, to be held on October 31, 2023.   The last day of trading in the Company’s shares including the right to receive unit rights is October 31, 2023. The first day of trading in the Company’s shares excluding the right to receive unit rights is November 1, 2023. The record date is November 2, 2023.   The shareholders of the Company will receive one (1) unit right for each (1) share held per the record date.

Buy-backs of shares in SSAB during week 43 2023

During the period 26–27 October 2023, SSAB AB (publ) (LEI 529900329VS14ZIML164) has repurchased in total 806,500 own shares, of which 195,500 shares of series A (ISIN: SE0000171100) and 611,000 shares of series B (ISIN: SE0000120669), as part of the share buy-back program initiated by the Board of Directors with the purpose to adjust the company’s capital structure so as to create greater value for the company’s shareholders.The share buy-back program, which SSAB announced on 25 October 2023 and which runs between 26 October 2023 and 11 March 2024, at the latest, is being carried out in

Form 8.3 - EMIS Group Plc

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1.         KEY INFORMATION (a) Full name of discloser: Magnetar Capital Partners LP(b) Owner or controller of interests and shortpositions disclosed, if different from 1(a):    The naming of nominee or vehicle companies isinsufficient.  For a trust, the trustee(s),settlor and beneficiaries must be named.(c) Name of offeror/offeree in relation to whose EMIS Group

Form 8.3 - Dechra Pharmaceuticals plc

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1.         KEY INFORMATION (a) Full name of discloser: Magnetar Capital Partners LP(b) Owner or controller of interests and shortpositions disclosed, if different from 1(a):    The naming of nominee or vehicle companies isinsufficient.  For a trust, the trustee(s),settlor and beneficiaries must be named.(c) Name of offeror/offeree in relation to whose Dechra

Calmark Sweden AB: CEO-interview with Finwire

Calmark Sweden AB's ("Calmark" or "the Company") CEO Anna Söderlund has been interviewed by Finwire TV. The video interview has been published and is available via link below. The subscription period in the Company’s rights issue of units runs until the 10[th] of November 2023.NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, HONG KONG, JAPAN, CANADA, NEW ZEALAND, SWITZERLAND, SINGAPORE, SOUTH AFRICA, SOUTH KOREA, RUSSIA, BELARUS OR IN ANY OTHER JURISDICTION WHERE THE DISTRIBUTION OF THIS PRESS RELEASE WOULD BE UNLAWFUL OR REQUIRE

Shocking - The Dirtiest Part of Your Bathroom Revealed and How to Clean It

Do you know what the dirtiest part of your bathroom is? Many people are shocked when they find out that their toilet isn’t actually the dirtiest part of the bathroom. So, if you’re wondering what the dirtiest part of your bathroom actually is, then this article is for you.   [A hand cleaning a tile floor Description automatically generated]   Cleaning expert Sarah Dempsey at MyJobQuote.co.uk  reveals what the dirtiest part of your bathroom is below. She also provides tips on the best ways to clean this area. Read on to find out more.   What

Half-year Report

LIMITLESS EARTH PLC ("Limitless" or the "Company") UNAUDITED HALF-YEARLY RESULTS FOR THE SIX MONTHS ENDED 31 JULY 2023 The Company announces its half-yearly result for the six months to 31 July 2023. CHIEF EXECUTIVE’S STATEMENT Limitless is an investing company that focuses on making investments in and assisting companies that show potential to generate returns through capital appreciation.  The directors look to make investments in small companies that have clear growth strategies and operate in sectors that have long-term growth prospects and are driven by demographic

Neste recognized as a Leader in Global Child Forum’s benchmark for 2023

Neste Corporation, Press Release, 30 October 2023 at 3 p.m. (EET) Neste has been recognized as a Leader in Global Child Forum’s global children’s rights and business benchmark, The State of Children’s Rights and Business 2023. Global Child Forum is a Swedish non-profit foundation benchmarking the world's most influential companies, assessing how they respond to children's rights. Neste was ranked among the top 15 companies out of the 795 benchmarked companies across eight sectors and six regions and placed as 2nd out of the 119 companies in the energy and utilities sector. The

Shape Robotics - update on Nasdaq Copenhagen (Main Market) listing

Investor news – October 2023 As stated in Company Announcement No. 12-23, Shape Robotics is in the process of preparing for an up-listing to Nasdaq Copenhagen (Main Market) in 2023. The company has successfully migrated from the "Danish Financial Statement Act" to adhere to the International Financial Reporting Standards (IFRS). With this transition, the company anticipates releasing the Q3 2023 financial report (covering January to September) on November 14, 2023, in compliance with IFRS standards. In parallel, the company is on track concerning preparing the necessary documents

Financial calendar

Financial calendar for Aker Horizons ASAFINANCIAL YEAR 2023 20.03.2024 - Annual Report 02.11.2023 - Quarterly Report - Q315.02.2024 - Quarterly Report - Q4  FINANCIAL YEAR 2024 16.07.2024 - Half-yearly Report17.04.2024 - Annual General Meeting 30.04.2024 - Quarterly Report - Q101.11.2024 - Quarterly Report - Q3  This information is published pursuant to the requirements set out in the Continuing obligations. About Aker Horizons Aker Horizons develops green energy and green industry to accelerate the transition to net zero. The company is active in renewable

Getinge Announces U.S. Commercial Availability of iCast Covered Stent System for Treatment of Iliac Arterial Occlusive Disease

Today Getinge announced commercial availability of the iCast covered stent system in the United States for the treatment of iliac arterial occlusive disease. In March 2023, the iCast covered stent received premarket approval from the U.S. Food and Drug Administration (FDA) for the treatment of iliac arterial occlusive disease. Lower extremity peripheral artery disease (PAD) is estimated to affect approximately 8.5 million people in the U.S. per year [[[1]]][,[[2]]].“We are very pleased that the iCast covered stent is now available to clinicians and hospital systems throughout the U.S. for

Invitation to webcast and teleconference in connection with Arise´s interim report 1 January–30 September 2023

Arise’s interim report 1 January – 30 September 2023 will be released on Wednesday 15 November, 2023 08.00 CET. At 11.00 on the same day a webcast and teleconference will be held, hosted by Per-Erik Eriksson, CEO and Markus Larsson, CFO, who will present the report to the stock market and media. After the presentation those attending will be invited to ask questions. If you wish to participate via webcast please use the link below. Via the webcast you are able to ask written questions. Arise Q3 Report 2023 (financialhearings.com) 

ADDvise Group successfully issues subsequent senior secured bonds of SEK 450 million

ADDvise Group AB (publ) has successfully issued subsequent senior secured bonds of SEK 450 million under its existing bond loan with ISIN SE0020180271. Following the bond issue, in total SEK 1,450 million will be outstanding under the framework. The subsequent bonds was priced at 101.75% of par and carry a floating interest rate of STIBOR 3m plus 5.50 per cent per annum. The settlement date for the bond issue is expected to be 20 November 2023. The bond issue was met with strong demand from Nordic and international institutional investors and was upsized by SEK 50 million on the back of

SAGAX´S NOMINATION COMMITTEE HAS BEEN APPOINTED

According to the principles for the appointment of Sagax's nomination committee, which was decided at the Annual General Meeting 2021, the chairman of the board has convened a nomination committee for the 2024 Annual General Meeting According to the instructions, Sagax's nomination committee shall consist of four members, of which one member shall be the chairman of the board. The three largest shareholders in terms of votes as of September 30, 2023, shall each appoint a representative to form the nomination committee together with the chairman of the board. Nomination committee for

Stable profitability despite lower sales

The third quarter: July – The interim period:September January– September · Net sales amounted to 253 · Net sales amounted toMSEK (311) 925 MSEK (950) · Order intake amounted to · Order intake amounted135 MSEK (265) to 682 MSEK (921) · Order backlog amounted to · Adjusted operating1,067 MSEK (1,461) profit (EBITA) amounted to · Adjusted operating profit 74 MSEK (73)(EBITA) amounted to 15 MSEK · Operating profit(17) (EBITA)

Kesko Oyj - Managers' Transactions (Kiiskinen)

Kesko Oyj - Managers' Transactions____________________________________________Person subject to the notification requirementName: Esa KiiskinenPosition: Member of the Board/Deputy memberIssuer: Kesko OyjLEI: 743700OX6HSVMCAHPB95Notification type: INITIAL NOTIFICATIONReference number: 41890/11/16____________________________________________Transaction date: 2023-10-26Venue: NASDAQ HELSINKI LTD (XHEL)Instrument type: SHAREISIN: FI0009007900Nature of transaction: ACQUISITIONTransaction details(1): Volume: 12 Unit price: 15.78 EUR(2): Volume: 2 Unit price: 15.78

There are no items matching the current filter
There are no more items matching the current filter
Back to top